Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
82,244 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 22, 2026 | HealthPartners | Tisotumab vedotin (Tivdak) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-247637 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Teprotumumab-trbw (Tepezza) and veligrotug-vvze (Lumvoa) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-231638 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Teprotumumab-trbw (Tepezza) and veligrotug-vvze (Lumvoa)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-226990 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Teplizumab (Tzield)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-260047 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Sutimlimab-jome (Enjaymo)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-249186 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Spesolimab-sbzo (Spevigo)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-254279 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Somatostatin analogues for acromegaly (Sandostatin LAR, Somatuline Depot, Signifor LAR, Somavert, Lanreotide)PayerPolicy · HEALTHPARTNERS-CC-AENTRY-046147 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Satralizumab-mwge (Enspryng) and inebilizumab-cdon (Uplizna)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-231391 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Romosozumab-aqqg (Evenity)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-212858 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Remestemcel-L-rknd (Ryoncil)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-286215 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Prostaglandin intracameral implants: travoprost intracameral implant (iDose TR, Durysta)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-287103 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Pompe disease enzyme replacement therapy: alglucosidase alfa (Lumizyme), avalglucosidase alfa-ngpt (Nexviazyme), cipaglucosidase alfa-atga (Pombiliti) - Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-187832 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Pompe disease enzyme replacement therapy: alglucosidase alfa (Lumizyme), avalglucosidase alfa-ngpt (Nexviazyme), cipaglucosidase alfa-atga (Pombiliti)PayerPolicy · HEALTHPARTNERS-CC-AENTRY-045970 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Pegloticase (Krystexxa)PayerPolicy · HEALTHPARTNERS-CC-AENTRY-046270 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology** - rituximab (Rituxan, Ruxience, Truxima, Rituxan Hycela, and Riabni) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-228488 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology** - rituximab (Rituxan, Ruxience, Truxima, Rituxan Hycela, and Riabni)PayerPolicy · HEALTHPARTNERS-CC-AENTRY-046128 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - trastuzumab (Herceptin, Herzuma, Kanjinti, Ogivri, Ontruzant, Trazimera), and trastuzumab and hyaluronidase-oysk (Herceptin Hylecta)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-237405 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - trabectedin (Yondelis) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-234241 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - teclistamab-cqyv (Tecvayli)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-287054 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - talimogene laherparepvec (Imlygic) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-234242 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - tagraxofusp-erzs (Elzonris) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-227133 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - tagraxofusp-erzs (Elzonris)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-210226 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - tafasitamab-cxix (Monjuvi) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-233977 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - sacituzumab govitecan-hziy (Trodelvy) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-231639 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - polatuzumab Vedotin-piiq (Polivy) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-233978 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - pertuzumab, trastuzumab, and hyaluronidase-zzxf (Phesgo) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-233979 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - mosunetuzumab-axgb (Lunsumio)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-287053 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - luspatercept-aamt (Reblozyl) and imetelstat (Rytelo)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-226974 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - isatuximab-irfc (Sarclisa) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-231645 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - ipilimumab (Yervoy)PayerPolicy · HEALTHPARTNERS-CC-AENTRY-046023 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - inotuzumab ozogamicin (Besponsa) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-202917 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - gene therapy for bladder cancer (Adstiladrin)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-266662 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - gemcitabine intravesical system (Inlexzo)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-287010 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - fam-trastuzumab deruxtecan-nxki (Enhertu) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-226852 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - emapalumab-lzsg (Gamifant)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-210222 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - datopotamab deruxtecan-dlnk (Datroway)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-284657 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - daratumumab and daratumumab hyaluronidase-fihj (Darzalex and Darzalex Faspro)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-267748 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - brentuximab vedotin (Adcetris) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-231701 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - blinatumomab (Blincyto)PayerPolicy · HEALTHPARTNERS-CC-AENTRY-045816 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - bevacizumab (Avastin, Mvasi, Zirabev, Alymsys, Vegzelma, Jobevne)PayerPolicy · HEALTHPARTNERS-CC-AENTRY-045654 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - belantamab (Blenrep) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-233951 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - ado-trastuzumab emtansine (Kadcyla), pertuzumab (Perjeta), trastuzumab (Herceptin, Herzuma, Kanjinti, Ogivri, Ontruzant, Trazimera), and trastuzumab and hyaluronidase-oysk (Herceptin Hylecta) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-227137 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Oncology - ado-trastuzumab emtansine (Kadcyla), fam-trastuzumab deruxtecan-nxki (Enhertu), pertuzumab (Perjeta)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-203715 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Omadacycline (Nuzyra) – Minnesota Healthcare ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-217831 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Olipudase alfa-rpcp (Xenpozyme)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-257855 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Ocrelizumab (Ocrevus) and Ocrelizumab hya-ocsq (Ocrevus Zunovo) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-194059 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Ocrelizumab (Ocrevus) and Ocrelizumab hya-ocsq (Ocrevus Zunovo)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-193159 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Neonatal Fc receptor antagonists (Vyvgart, Vyvgart Hytrulo, Rystiggo, Imaavy)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-252184 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Natalizumab (Tysabri, Tyruko) - Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-187829 | Codes changed |
|---|
| Aug 22, 2026 | HealthPartners | Natalizumab (Tysabri, Tyruko)PayerPolicy · HEALTHPARTNERS-CC-AENTRY-046241 | Codes changed |
|---|